6th Edition of Cardiology World Conference
September 15-17, 2025 | London, UK
Dyslipidemia
Dyslipidemia is a medical condition marked by an abnormal lipid profile, encompassing cholesterol and triglycerides in the bloodstream. Its significance lies in its association with the development of cardiovascular diseases, notably atherosclerosis and coronary artery disease. This condition arises from disruptions in lipid production, utilization, or clearance, resulting in elevated levels of LDL cholesterol, often termed "bad" cholesterol, and decreased levels of HDL cholesterol, referred to as "good" cholesterol. Contributing factors to dyslipidemia include a combination of genetic predisposition, lifestyle choices, and underlying health conditions. Unhealthy dietary patterns, sedentary lifestyle, and obesity play substantial roles in its onset.
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Gustavo Lionel Knop
Mayo Clinic, United States
Arthur J Siegel
Massachusetts General Hospital, United States
Sekib Sokolovic
Sarajevo School of Science and Technology, Medical Faculty, ASA Hospital, Bosnia and Herzegowina
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Iris Panagiota Efthymiou
University of Greenwich, United KingdomSubmit your abstract Today
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands